Dr.
Leroy Hood
Professor
François Baneyx
Dr. Leroy Hood
President, Institute for Systems Biology
Monday 28th June
Seattle, WA
"Systems Biology and the Networks of Life".
Systems approaches to biology attempt to define
the elements
of a given biological system, measure their interactions
and from this
come to understand the systems behavior. This view has emerged
from
the human genome project in that a genetics parts list was
provided
(identification of all genes and proteins) enabling the analyses
of
many of life's elements. The systems views leads to the idea
that
biology is an informational science and the central importance
of high
throughput biological platforms for measuring biological
data (DNA
sequencing production lines, DNA arrays, etc.). I will talk
about
these and give an example or two of biological systems that
we have
studied. I will then point out how systems biology inevitably
leads
to a revolution in medicine--from our current reactive medicine
to a
predictive, preventive and personalized medicine.
Dr.
Leroy Hood is recognized as one of the world's leading scientists
in molecular biotechnology and genomics.
http://www.systemsbiology.org/Default.aspx?pagename=leroyhood
Dr. Leroy Hood
President, Institute for Systems Biology
M.D., Johns Hopkins School of Medicine, 1964
Ph.D., Biochemistry, California Institute of Technology,
1968
Biographical
sketch for Leroy Hood
Dr.
Hood’s research has focused on the study of molecular
immunology, biotechnology, and genomics. His professional
career began at Caltech where he and his colleagues pioneered
four instruments—the DNA gene sequencer and synthesizer,
and the protein synthesizer and sequencer—which comprise
the technological foundation for contemporary molecular
biology. In particular, the DNA sequencer has revolutionized
genomics by allowing the rapid automated sequencing of
DNA, which played a crucial role in contributing to the
successful mapping of the human genome during the 1990s.
In 1992, Dr. Hood moved to the University of Washington
as founder and Chairman of the cross-disciplinary Department
of Molecular Biotechnology. In 2000, he co-founded the
Institute for Systems Biology in Seattle, Washington to
pioneer systems approaches to biology and medicine. Most
recently, Dr. Hood's lifelong contributions to biotechnology
have earned him the prestigious 2003 Lemelson–MIT
Prize for Innovation and Invention. He was also awarded
the 2002 Kyoto Prize in Advanced Technology and the 1987
Lasker Prize for his studies on the mechanism of immune
diversity. He has published more than 500 peer-reviewed
papers, received 14 patents, and has co-authored textbooks
in biochemistry, immunology, molecular biology, and genetics,
and is a member of the National Academy of Sciences, the
American Philosophical Society, the American Association
of Arts and Sciences, and the Institute of Medicine. Dr.
Hood has also played a role in founding numerous biotechnology
companies, including Amgen, Applied Biosystems, Systemix,
Darwin and Rosetta.
Dr. Leroy Hood
President, Institute for Systems Biology
M.D., Johns Hopkins School of Medicine, 1964
Ph.D., Biochemistry, California Institute of Technology,
1968
''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''
Professor
François
Baneyx
Professor of Chemical Engineering and adjunct Professor
of Bioengineering. Center for Nanotechnology at University
of
Washington.
Tuesday 29th June
Seattle, WA
"Nanotechnology: current
status and forthcoming challenges"
The ability to synthesize, manipulate and organize nanometer-size
objects into functional structures holds enormous promise
in our quest for new materials, opto-electronics devices,
computational tools and for a variety of biotechnological
and biomedical applications. To realize the promise of
nanotechnology, significant hurdles will have to be overcome.
In this presentation, I will showcase groundbreaking research
in nanoscience and nanotechnogy by members of the University
of Washington Center for Nanotechnology, highlight the
challenges of the discipline and discuss how convergence
with computational approaches may help overcome current
hurdles.
Professor
Baneyx is a recognised international expert in biotechnology
and nano technology.
http://www.nano.washington.edu/about/faculty.asp
Biographical
sketch for François
Baneyx
Dr. Baneyx earned his Ph.D. in Chemical Engineering from
the University of Texas at Austin in 1991 and was a Visiting
Scientist for one year at the Du Pont Experimental Station
in Wilmington, DE. In 1992, he joined the Department of
Chemical Engineering at the University of Washington, Seattle,
where he is currently Professor of Chemical Engineering
and Bioengineering and co-director of the Center for Nanotechnology.
Dr. Baneyx holds three patents, has authored one textbook,
edited one volume and contributed over fifty scientific
papers. His research interests include molecular chaperones,
protein folding, protein expression, microbial-based sensing
and computation, molecular biomimetics and nanobiotechnology.
